StockNews.com assumed coverage on shares of Athersys (NASDAQ:ATHX – Free Report) in a research report sent to investors on Wednesday morning. The firm issued a hold rating on the biopharmaceutical company’s stock.
Athersys Stock Performance
The firm has a market capitalization of $833,000.00, a price-to-earnings ratio of -0.01 and a beta of -0.90. Athersys has a twelve month low of $0.01 and a twelve month high of $1.99.
Athersys Company Profile
Want More Great Investing Ideas?
Recommended Stories
- Five stocks we like better than Athersys
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Goldilocks CPI Report Leads Market to Sell Off, Lower Lows Ahead
- What Investors Need to Know About Upcoming IPOs
- GameStop: Earnings Won’t Save It, Dilution Points to Trouble
- 5 discounted opportunities for dividend growth investors
- Dividend Aristocrats or Dividend Kings: Which Is Best for You?
Receive News & Ratings for Athersys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Athersys and related companies with MarketBeat.com's FREE daily email newsletter.